CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463011414
- Phone
- 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- S-1 Offering Registration Statement
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement · Unregistered share sale · Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K Report Annual Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
Page 26 of 29 · 576 filings